Script Health

Market position

The company positions itself within the pharmacist-prescribing and retail-clinic-alternative segment of U.S. healthcare, citing physician shortage projections of 37,800 to 124,000 by 2034 and the presence of more than 300,000 U.S. pharmacists, along with the fact that the large majority of Americans live within five miles of a pharmacy. It has been a member of the MATTER healthcare startup community and has been featured in Deloitte's "The Pharmacist of the Future" report and in national business and technology press.

Company leadership describes Scripted as a turnkey offering that covers the full workflow — patient intake, clinical decision support, prescribing and downstream coordination with the patient's physician — whereas competing approaches are characterized as fragmented, addressing only reimbursement streamlining, workflow, or connecting patients to physicians. The platform is built around the premise that pharmacists, given decision support and enablement, can practice at the top of their licenses.

Technology

The product comprises a consumer-facing intake flow with a pharmacy locator and condition-specific questionnaires, and a pharmacist portal that delivers instant notifications, presents patient responses, and embeds clinical decision support that surfaces complicating factors (for example, flagging possible explanations for an irregular menstrual history in a UTI assessment). Prescriptions are generated within the platform and automatically faxed to the patient's primary care physician.

Go-to-market

Patients are acquired through the scripted.co website and pharmacy locator, through QR-code signage placed in participating pharmacies, and directly at the pharmacy counter where staff can enroll walk-ins. Distribution to pharmacies has included a partnership with CPESN intended to reach thousands of locations, supported by public advocacy such as the #PharmacyPaybackTime campaign and extensive podcast and trade-press appearances by the CEO.

Independent and community pharmacies and their pharmacists, and consumers seeking same-day, low-cost care for common non-urgent conditions such as UTIs, cold sores, seasonal allergies, mild acne, contraception and vaccinations.

Geography

The company operates in the United States, with a network of affiliated pharmacies located via a ZIP-code-based locator; its first patient was served in a small town in Idaho, and coverage has referenced pharmacies in Illinois and Florida.

History

The concept emerged from founder James Lott's experience as a pharmacy manager and from his time at the University of Chicago's Harris School of Public Policy and the Polsky Center for Entrepreneurship and Innovation's New Venture Challenge, where he initially worked on an opioid-response venture, naloxoneexchange.com, allowing consumers to order naloxone online. After a large pharmacy chain took notice of the press coverage, the team shifted its model toward enabling pharmacists to prescribe at the local store level. The company has been a member of the MATTER healthcare incubator, which profiled it in March 2022 and again in May 2024, and its company page lists participation in Techstars Boston/Chicago accelerator coverage and a SoftBank investment program for diverse founders. Press and podcast coverage between 2020 and 2022 included Bloomberg, TechCrunch, Crain's Chicago Business, MedCity News and Florida Today. By 2024 the company had partnered with CPESN to reach additional pharmacies and launched its #PharmacyPaybackTime campaign.

Risks & controversies

The company's public advocacy centers on reimbursement rates set by pharmacy benefit managers, which its CEO says are unsustainably low and are contributing to closures among small and independent pharmacies; the viability of pharmacist-delivered clinical services also depends on scope-of-practice and prescribing rules, which have varied by state and by temporary pandemic-era authorities such as the FDA allowance for pharmacists to prescribe COVID-19 treatment.